Your source for technology insights, tutorials, and guides.
Purdue Pharma dissolves after federal judge approves criminal sentence, replacing it with a public-benefit company as part of a landmark opioid settlement. The decision follows emotional victim testimony and addresses over 900,000 opioid-related deaths since 1999.
The US fertility decline reflects economic pressures like childcare costs, housing unaffordability, healthcare gaps, and no paid leave, not just personal choices. Policy support needed.
Julia Vitarello, whose daughter received a bespoke genetic therapy, is launching a new biotech to scale individualized treatments for rare mutations.
FDA survey finds low levels of PFAS (forever chemicals) in half of infant formula samples, but most at less than 2.9 ppt, indicating overall safety while experts call for continued reduction efforts.
As psychedelic therapies gain traction, people of color face barriers in access and research. This article examines disparities and proposes equity measures.
PFAS 'forever chemicals' persist in some infant formulas despite regulatory efforts. This article explores sources, health risks for infants, and practical steps parents can take to reduce exposure.
Explores humility as a core value across professions, using a designer's journey through the early web to illustrate how embracing humility fosters growth, collaboration, and better outcomes.
User research follows a three-act storytelling structure: setup (foundational research), conflict (formative research), and resolution (summative research). Using this framework engages stakeholders and makes insights memorable.
Design systems should function as living languages, speaking dialects for different contexts. Rigid consistency fails; adaptation solves real problems, as shown by Booking.com and Shopify cases.
Explores why well-meaning designers create inaccessible sites and offers a solution based on Nielsen's heuristic of recognition over recall to embed accessibility naturally.
Explore Gemma 4's role in on-device AI, its NVIDIA-optimized variants, capabilities, performance, and how OpenClaw enables local agentic assistants.
At Hannover Messe 2026, NVIDIA and partners showcase AI-driven manufacturing with the Industrial AI Cloud, AI-accelerated engineering, and robotics, demonstrating the factory of the future in action.
Discover NVIDIA's Nemotron 3 Nano Omni, an open omni-modal model unifying vision, audio, and language for up to 9x more efficient AI agents.
Q&A on Akeso's ivonescimab ASCO plenary: what survival data means, comparisons to rivals, implications for Summit, and key points to watch.
Wildfire smoke is increasingly harmful, with data showing rising PM2.5 levels causing more health issues like asthma and heart attacks, especially among vulnerable groups.
Q&A covering AstraZeneca's $400M UK expansion revived after US-UK trade deal, and US Supreme Court hearing on skinny labeling in Amarin v. Hikma case.
Democrats, led by Chuck Schumer, propose sweeping health care affordability measures including drug price negotiation, expanded subsidies, and hospital pricing reforms. Obstacles include partisan gridlock and industry lobbying.
Cigna's exit from ACA individual markets in 2027 explained: reasons, impact on 369K members, and focus on Evernorth, PBM, and employer plans.
Hinge Health expands beyond MSK into migraine with a new FDA-cleared neuromodulation device. Learn how it works, who it's for, and what it means for digital health.
A preclinical obesity drug with five mechanisms shows promise in mice. Also: NIH funding crisis, Novartis reshoring, Alzheimer's setback, and more.